Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion...
Rivus Pharmaceuticals’ $132 Million Series B Financing
Medical Microinstruments’ $75 Million Series B Round
Orrick advised Medical Microinstruments on the deal, while McDermott Will & Emery assisted the investors. Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical...
RA Capital Nexus Fund III’s $880 Million Fundraising
Proskauer advised RA Capital Management on the deal. RA Capital Management, LP, a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and...
Forge Biologics’ $120 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
Graphite Bio’s $150-Million Series B Financing
Brown Rudnick LLP advised the lead investors RA Capital Management and Rock Springs Capital Management on the deal. RA Capital Management and Rock Springs Capital Management...
Century Therapeutics’ $160-million Series C Financing
Brown Rudnick LLP advised lead investor Casdin Capital and a syndicate of new investors, while White & Case LLP advised Qatar Investment Authority on the deal....